BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2674085)

  • 1. Dosimetric considerations of stereotactic brain implants.
    Saw CB; Suntharalingam N; Ayyangar KM; Tupchong L
    Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):887-91. PubMed ID: 2674085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal brain irradiation during stereotactic brain implants using radioactive iodine-125.
    Jani SK; Hitchon PW; VanGilder JC; Wen BC
    Appl Neurophysiol; 1987; 50(1-6):310-3. PubMed ID: 3329869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A CT-based computerized treatment planning system for I-125 stereotactic brain implants.
    Weaver K; Smith V; Lewis JD; Lulu B; Barnett CM; Leibel SA; Gutin P; Larson D; Phillips T
    Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):445-54. PubMed ID: 2406230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplanar CT-guided stereotaxis and 125I interstitial radiotherapy. Image-guided tumor volume assessment, planning, dosimetric calculations, stereotactic biopsy and implantation of removable catheters.
    Zamorano L; Dujovny M; Malik G; Yakar D; Mehta B
    Appl Neurophysiol; 1987; 50(1-6):281-6. PubMed ID: 3329864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computerized optimization of 125I implants in brain tumors.
    Bauer-Kirpes B; Sturm V; Schlegel W; Lorenz WJ
    Int J Radiat Oncol Biol Phys; 1988 May; 14(5):1013-23. PubMed ID: 3283081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NCI-atlas of dose distributions for regular 125I brain implants.
    Rosenow UF; Findlay PA; Wright DC
    Radiother Oncol; 1987 Oct; 10(2):127-39. PubMed ID: 3423302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Volumetric changes following 125I interstitial brachytherapy of gliomas].
    Julow J; Viola A; Major T; Mangel L; Bajzik G; Repa I; Sági S; Valálik I; Emri M; Trón L; Németh G
    Ideggyogy Sz; 2005 Mar; 58(3-4):120-32. PubMed ID: 15887415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A versatile method for planning stereotactic brain implants.
    Anderson LL; Harrington PJ; Osian AD; Arbit E; Leibel SA; Malkin MG
    Med Phys; 1993; 20(5):1457-64. PubMed ID: 8289729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic treatment of brain tumors with radioactive implants or external photon beams: radiobiophysical aspects.
    Ling CC; Chui CS
    Radiother Oncol; 1993 Jan; 26(1):11-8. PubMed ID: 8438081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choice of radioisotope in stereotactic interstitial radiotherapy of small brain tumors.
    Jani SK; Hitchon PW; VanGilder JC; Pennington EC; Hussey DH
    Appl Neurophysiol; 1987; 50(1-6):295-301. PubMed ID: 3329867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 125I interstitial brachytherapy for primary malignant brain tumors: technical aspects of treatment planning and implantation methods.
    Findlay PA; Wright DC; Rosenow U; Harrington FS; Miller RW
    Int J Radiat Oncol Biol Phys; 1985 Nov; 11(11):2021-6. PubMed ID: 4055458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric properties of a novel brachytherapy balloon applicator for the treatment of malignant brain-tumor resection-cavity margins.
    Dempsey JF; Williams JA; Stubbs JB; Patrick TJ; Williamson JF
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):421-9. PubMed ID: 9788425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view.
    Nickers P; Thissen B; Jansen N; Deneufbourg JM
    Radiother Oncol; 2006 Jan; 78(1):47-52. PubMed ID: 16216365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of various dosimetric quality indicators in prostate brachytherapy.
    Merrick GS; Butler WM; Dorsey AT; Lief JH
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):717-24. PubMed ID: 10348304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A stereotactic brain implant technique with high activity I-125 seeds using a conventional brachytherapy treatment planning system.
    Niroomand-Rad A; Cumberlin R; Rosa L; Rodgers JE
    Radiat Med; 1993; 11(1):36-41. PubMed ID: 8516454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anisotropy functions for 103Pd, 125I, and 192Ir interstitial brachytherapy sources.
    Nath R; Meigooni AS; Muench P; Melillo A
    Med Phys; 1993; 20(5):1465-73. PubMed ID: 8289730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of low malignancy brain neoplasms by means of stereotactic interstitial radiotherapy.
    Frank F; Fabrizi AP; Frank-Ricci R; Sturiale C; Nuzzo G
    Appl Neurophysiol; 1985; 48(1-6):121-6. PubMed ID: 3915641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic interstitial brachytherapy--current concepts and concerns in twenty patients.
    Lunsford LD; Deutsch M; Yoder V
    Appl Neurophysiol; 1985; 48(1-6):117-20. PubMed ID: 3915640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-activity 125I interstitial irradiation in the treatment of pediatric central nervous system tumors: a pilot study.
    Fontanesi J; Heideman RL; Muhlbauer M; Mulhern R; Sanford RA; Douglass EC; Kovnar E; Ochs JJ; Kuttesch JF; Tai D
    Pediatr Neurosurg; 1995; 22(6):289-97; discussion 98. PubMed ID: 7577662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of anisotropic data in 125I prostate implants.
    Fox RA; Haworth A; Mina LL
    Australas Phys Eng Sci Med; 1997 Jun; 20(2):57-63. PubMed ID: 9262024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.